Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7

다국어 초록 (Multilingual Abstract)

Background: The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis.Methods: Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis.Results: SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro.Conclusion: Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7.

참고문헌 (Reference)

1 Sun XY, "Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress induced apoptosis" 13 : 661-668, 2016

2 Tan G, "Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication" 15 : 272-281, 2018

3 Hakami NY, "Trichostatin A, a histone deacetylase inhibitor suppresses NADPH oxidase 4-derived redox signalling and angiogenesis" 20 : 1932-1944, 2016

4 Zheng H, "Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy" 60 : 3055-3066, 2011

5 Abbaoui B, "The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer" 156 : 94-103, 2017

6 Manson SR, "The BMP7-Smad1/5/8 pathway promotes kidney repair after obstruction induced renal injury" 185 : 2523-2530, 2011

7 Kim BG, "Sulforaphane, a natural component of broccoli, inhibits vestibular schwannoma growth in vitro and in vivo" 6 : 36215-, 2016

8 Shang G, "Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway" 26 : 596-606, 2015

9 Khan S, "Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat" 98 : 230-239, 2015

10 Kong L, "Sirtuin 1 : a target for kidney diseases" 21 : 87-97, 2015

11 Meng XM, "Role of the TGF-β/BMP-7/Smad pathways in renal diseases" 124 : 243-254, 2013

12 Wang S, "Renal bone morphogenetic protein-7 protects against diabetic nephropathy" 17 : 2504-2512, 2006

13 Guerrero-Beltran CE, "Protective effect of sulforaphane against oxidative stress : recent advances" 64 : 503-508, 2012

14 Cui W, "Prevention of diabetic nephropathy by sulforaphane : possible role of Nrf2upregulation and activation" 2012 : 821936-, 2012

15 Cui W, "Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice" 304 : E87-99, 2013

16 Vukicevic S, "Osteogenic protein-1(bone morphogenetic protein-7)reduces severity of injury after ischemic acute renal failure in rat" 102 : 202-214, 1998

17 Hruska KA, "Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction" 279 : F130-43, 2000

18 Klahr S, "New approaches to delay the progression of chronic renal failure" 23-26, 2002

19 Wu H, "Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2" 89 : 431-442, 2015

20 Martin SL, "Mechanisms for the inhibition of colon cancer cells by sulforaphane through epigenetic modulation of microRNA-21 and human telomerase reverse transcriptase(hTERT)down-regulation" 18 : 97-106, 2018

21 Wang SN, "Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy" 12 : 2392-2399, 2001

22 Yoshikawa M, "Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells" 18 : 58-65, 2007

23 Choi SY, "Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat" 101 : 145-154, 2018

24 Noh H, "Histone deacetylase-2 is a key regulator of diabetes-and transforming growth factor-beta1-induced renal injury" 297 : F729-39, 2009

25 Chen Y, "Histone deacetylase(HDAC)inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice" 14 : 99-, 2015

26 이은조, "Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats" 대한약리학회 20 (20): 477-485, 2016

27 Anderson L, "Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni" 11 : e0005539-, 2017

28 Manson SR, "HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-β mediated renal fibrosis in obstructive uropathy" 191 : 242-252, 2014

29 Singh RS, "Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury : potential role as a histone deacetylase inhibitor" 6 : 38034-, 2016

30 Song Y, "Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation" 76 : 66-75, 2004

31 Theocharis AD, "Extracellular matrix structure" 97 : 4-27, 2016

32 Marumo T, "Epigenetic regulation of BMP7 in the regenerative response to ischemia" 19 : 1311-1320, 2008

33 Pan B, "Epigallocatechin gallate reverses cTnI-low expression-induced age-related heart diastolic dysfunction through histone acetylation modification" 21 : 2481-2490, 2017

34 Manson SR, "Endogenous BMP-7 is a critical molecular determinant of the reversibility of obstruction-induced renal injuries" 301 : F1293-302, 2011

35 Zhu P, "Effect and mechanism of inhibition of lipopolysaccharide-induced pulmonary fibrosis by butyric acid" 28 : 8-14, 2016

36 Zeisberg M, "Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models" 285 : F1060-7, 2003

37 Morrissey J, "Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function" 2002

38 Ivanac-Jankovic R, "BMP-7 protein expression is downregulated in human diabetic nephropathy" 54 : 164-168, 2015

39 Zeisberg M, "BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury" 9 : 964-968, 2003